Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Heliyon|March 15, 2024
Heart rate detection method based on Ballistocardiogram signal of wearable device:Algorithm development and validationDuyan Geng, Yue Yin, Zhigang Fu, et al.Frontiers in Oncology|February 13, 2026
Ceritinib efficacy in SMARCA4-deficient NSCLC harboring novel CTNND2 ALK/EML4-ALK fusion: case reportZhigang Fu, Gengda Huang, Jian Xie, et al.Applied Optics|November 2, 2019
Accuracy improvement of quantitative analysis in VIS-NIR spectroscopy using the GKF-WTEF algorithmXingwei Hou, Mengqiu Zhang, Gang Li, et al.Journal of Gastrointestinal Oncology|July 15, 2022
Comparison of the safety and prognosis of sequential regorafenib after sorafenib and lenvatinib treatment failure in patients with unresectable hepatocellular carcinoma: a retrospective cohort studyJian Zhai, Jianwei Liu, Zhigang Fu, et al.Journal of Interventional Medicine|May 19, 2022
Coexistence of situs inversus totalis and hepatocellular carcinoma: A series of nine cases and a literature reviewXiaowei Li, Zhigang Fu, Jiaming Zhong, et al.Journal of Advanced Research|April 7, 2026
UBTF-HSP90A-MIF stress circuit drives lenvatinib resistance and immune exclusion in hepatocellular carcinomaShiping Chen, Biao Wang, Yanfei Wu, et al.Future Oncology (London, England)|July 11, 2022
Efficacy and safety of drug-eluting beads bronchial arterial chemoembolization versus conventional bronchial arterial chemoembolization in lung cancer patients with hemoptysisZhigang Fu, Chunyan Wang, Wei Wei, et al.Hepatology International|April 20, 2021
Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled studyZhigang Fu, Xiaowei Li, Jiaming Zhong, et al.Frontiers in Oncology|July 21, 2022
Efficacy and Safety of Lenvatinib Combined With PD-1 Inhibitors Plus TACE for Unresectable Hepatocellular Carcinoma Patients in China Real-WorldXiaowei Li, Zhigang Fu, Xiaoxia Chen, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 3, 2025
Vascular stent graft for the treatment of post-pancreaticoduodenectomy hemorrhage and risk factors for rebleedingXiaowei Li, Zhigang Fu, Kunkun Cao, et al.Pageof 3